Close the acquisition of Seprafilm

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced: 13 Jan 2020
Due: 31 Mar 2020
Delivered: February 2020

Deadline
Met
Late
Not met
Today

What the company said

“the proposed Seprafilm acquisition, which is expected to close during the first quarter of 2020”

SourceBaxter International Form 8-K press release, 2020-01-13
FilingSEC filing index
Deadline as statedduring the first quarter of 2020
Deadline used31 Mar 2020, the last day of the stated period
TypeTransaction
Permanent referenceKI-C-2020-BAX-005254
Cite as https://keptindex.org/c/KI-C-2020-BAX-005254/ — this address never changes.

What we found

Evidence strength A What the grades mean

Baxter International completed the acquisition of Seprafilm in February 2020, which falls within the first quarter of 2020 as committed.

A
Baxter International 10-Q filed 2020-10-29 Regulatory filing · published 29 Oct 2020 · retrieved 8 Oct 2026 · kept permanently by the SEC · fingerprint 7d0ace408f55
“In February 2020, we completed the acquisition of the product rights to Seprafilm Adhesion Barrier (Seprafilm) from Sanofi for approximately $342 million in cash.” ✓ confirmed on the page

Market reaction: the shares moved -0.4% against the S&P 500 over the three sessions around the disclosure (28 Oct 2020 to 2 Nov 2020). What this measures

Checked 8 Oct 2026.

Commitment lineage

Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.

1 versions

Version 1 · original · stated 13 Jan 2020

Deadline 31 Mar 2020 (“during the first quarter of 2020”) · wording expected
Version 2 · stated 2 Sep 2021

Deadline 31 Mar 2022 (“by early 2022”) · wording expected

“The transaction is expected to close by early 2022.”
Source for this version

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type: Acquisition close
Indicative materiality: High rules
Action: Close
Deliverable: Seprafilm acquisition
Language: Expected (“expects”, “plans”)
In the company’s control: Medium
Specificity: High
Depends on: Regulatory, Counterparty

How this entry was checked

Commitment recordedThe company's words were matched word for word against the filing.
First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Baxter International? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.